PremiumCompany AnnouncementsLivzon Pharmaceutical Cancels Unexercised Share Options Livzon Pharmaceutical Updates Final Dividend Details for 2024 Livzon Pharmaceutical Announces Executive Resignation PremiumCompany AnnouncementsLivzon Pharmaceutical Clarifies Capital Contribution Details Livzon Pharmaceutical Group Reports Steady Profit Growth Livzon Pharmaceutical Group Announces 2024 Audited Financial Results PremiumPre-EarningsLVZPF Upcoming Earnings Report: What to Expect? Livzon Pharmaceutical Group Schedules Board Meeting for Annual Results Review Livzon Pharma Gains Clinical Trial Nod for Innovative Gastrointestinal Drug